Applications including "Metformin"

LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -

LC Technical Note InertSustain AQ-C18 InertSustain PFP
LB916 - Analysis of Metformin Hydrochloride -

LC InertSearch InertSustain C18
LB915 - Analysis of Metformin Hydrochloride -

LC InertSearch InertSustain C18
LB912 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB911 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB804 - Analysis of Metformin -

LC InertSearch Inertsil CX
LB745 - Analysis of of Metformin Hydrochloride Tablets（Under the Condeition of USP43-NF38, Glyburide and Metformin Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB692 - Analysis of Nitrosamines -

LC InertSearch InertSustain AQ-C18
LB691 - Analysis of Nitrosamines -

LC InertSearch InertSustain PFP
LB690 - Analysis of Nitrosamines -

LC InertSearch InertSustain PFP
LB548 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB547 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB204 - Analysis of Metformin hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C18
LB195 - Analysis of Metformin hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB194 - Analysis of Metformin hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB193 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB192 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB191 - Analysis of Metformin hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB190 - Analysis of Metformin hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3
LB189 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch InertSustain C8
LB188 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LC InertSearch Inertsil C8-3

Applications including "Metformin"

LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -

LB916 - Analysis of Metformin Hydrochloride -

LB915 - Analysis of Metformin Hydrochloride -

LB912 - Analysis of Metformin Hydrochloride -

LB911 - Analysis of Metformin Hydrochloride -

LB804 - Analysis of Metformin -

LB745 - Analysis of of Metformin Hydrochloride Tablets（Under the Condeition of USP43-NF38, Glyburide and Metformin Hydrochloride Tablets) -

LB692 - Analysis of Nitrosamines -

LB691 - Analysis of Nitrosamines -

LB690 - Analysis of Nitrosamines -

LB548 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LB547 - Analysis of Sitagliptin (Under the Condition of draft for USP, Sitagliptin and Metformin Hydrochloride Tablets) -

LB204 - Analysis of Metformin hydrochloride (Under the Condition of the Japanese Pharmacopoeia, Metformin hydrochloride Tablets) -

LB195 - Analysis of Metformin hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB194 - Analysis of Metformin hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB193 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB192 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB191 - Analysis of Metformin hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB190 - Analysis of Metformin hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB189 - Analysis of Pioglitazone hydrochloride (InertSustain C8) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

LB188 - Analysis of Pioglitazone hydrochloride (Inertsil C8-3) (Under the Condition of the Japanese Pharmacopoeia, Pioglitazone hydrochloride and Metformin hydrochloride Tablets) -

Application Search